UHS (UHS) Q1 2025: Behavioral Revenue Per Day Climbs 5.8% as Volume Recovery Lags

April 29, 2025 | By EarningsIQ Research

Behavioral health pricing continued to outpace volume at Universal Health Services in Q1, with revenue per adjusted day up sharply, but patient day growth still trailing management’s full-year target. Acute care volumes and disciplined cost control offset behavioral headwinds, though cash flow was pressured by delayed Medicaid payments. Management reaffirmed full-year guidance, but the path to behavioral growth will require a meaningful step-up in the coming quarters.

Summary

• Behavioral Volume Recovery Required: Patient day growth remains below target, putting pressure on back-half acceleration.
• Expense Controls Sustain Margin: Acute care and behavioral segments both benefited from disciplined cost management.
• Supplemental Medicaid Uncertainty Persists: Guidance excludes key state programs, highlighting ongoing regulatory risk.

Performance Analysis

Universal Health Services (UHS) delivered broad-based revenue growth in Q1 2025, with acute care hospital same-facility admissions up 2.4% and net revenues in the segment rising 5%. Behavioral health saw a 5.5% increase in net revenue, but this was driven almost entirely by a 5.8% rise in revenue per adjusted day, as adjusted patient days were flat year-over-year. Management attributed the weak volume growth to leap year comparisons and severe winter weather, but noted a re-acceleration in March.

Expense management was a standout, with operating expenses up just 2.6% in acute care and premium labor costs holding steady near $63 million. EBITDA rose 21% after excluding Medicaid supplement impacts, though operating cash flow fell to $360 million, reflecting delays in supplemental Medicaid payments. Capital expenditures totaled $239 million, and share repurchases reached $181 million in the quarter.

• Behavioral Revenue Mix Shift: Pricing gains outpaced volume, with managed Medicaid contracts driving higher rates.
• Acute Care Margin Stability: Expense controls and favorable payer mix offset flu-driven case mix changes.
• Cash Flow Timing Drag: Delayed Medicaid payments in key states dampened operating cash flow visibility.

While acute care delivered on both volume and price, behavioral health’s reliance on rate increases, rather than patient day growth, raises questions about the sustainability of current momentum as industry capacity expands.

Executive Commentary

Strategic Positioning

1. Behavioral Health: Pricing Power vs. Volume Challenge

UHS’s behavioral health segment continues to rely on pricing gains from managed Medicaid contracts, with revenue per adjusted day up 5.8%. However, patient day growth was flat, and management acknowledged the need for a step-up to reach the 2.5% to 3% annual growth target. Labor constraints and weather disruptions remain the primary bottlenecks, though management believes these headwinds are easing. The risk is that as capacity in the sector grows, pricing leverage may erode, making volume recovery even more critical for long-term growth.

2. Acute Care: Margin Defense and Market Expansion

Acute care saw stable volume and price growth, with a positive contribution from new facilities like West Henderson Hospital, which achieved positive EBITDA in its first full quarter. Cost management was effective, with supply expense inflation running below guidance and premium labor costs steady. Management expects acuity to normalize upward as flu season wanes, supporting further margin improvement. Expansion projects in growth markets remain a priority, with CapEx tracking toward the upper end of the original range.

3. Medicaid Supplemental Payments: Regulatory Overhang

Supplemental Medicaid payment programs remain a material source of cash flow volatility, with timing of approvals in Tennessee and D.C. still uncertain. Guidance does not assume new program approvals, and management signaled that future growth will rely more on organic volume and rate increases than on expanding supplemental payments. Potential legislative changes to provider tax caps and Medicaid funding formulas introduce additional risk, though UHS’s largest states are currently below the potential cap thresholds.

4. Capital Deployment: Buybacks and CapEx Flexibility

UHS maintained an active stance on capital allocation, repurchasing $181 million of shares in Q1 and signaling continued buybacks if market softness persists. CapEx was elevated at $239 million, reflecting ongoing hospital projects, but is expected to normalize over the year. Management remains committed to balancing growth investments with shareholder returns.

Key Considerations

This quarter highlights UHS’s dual reliance on behavioral health pricing and acute care volume, while exposing the fragility of behavioral volume recovery and the unpredictability of Medicaid supplemental payments. Expense discipline and capital allocation are core levers, but future growth will hinge on behavioral volume normalization and regulatory clarity.

Key Considerations:

• Behavioral Volume Step-Up Needed: Reaching the full-year patient day growth target will require sustained acceleration in the next three quarters.
• Supplemental Medicaid Approval Timing: Delays or denials in Tennessee and D.C. programs could further pressure cash flow and earnings visibility.
• Labor Market Stabilization: Premium pay and staffing costs have plateaued, but persistent labor tightness could cap behavioral capacity in select markets.
• Acute Care Expansion: New hospitals are delivering early returns, but cannibalization of existing facilities needs monitoring.
• Tariff and Supply Chain Insulation: Roughly three-quarters of supply chain spend is insulated from tariffs, reducing near-term inflation risk.

Risks

Regulatory risk around Medicaid supplemental payments remains elevated, with legislative changes or CMS delays posing a threat to both earnings and cash flow. Behavioral volume recovery is not assured, and continued reliance on pricing gains may become unsustainable as sector capacity expands. Labor market tightness and potential tariff impacts are secondary but persistent risks that could pressure margins if conditions worsen.

Forward Outlook

For Q2 2025, UHS guided to:

• Continued behavioral patient day growth acceleration, targeting 2.5% to 3% for the full year
• Acute care same-store revenue growth of 5% to 6%, with balanced price and volume contributions

For full-year 2025, management reiterated guidance:

• Behavioral health volume growth of 2.5% to 3% (requires step-up from Q1)
• No inclusion of Tennessee or D.C. Medicaid supplemental approvals in forecast

Leadership emphasized confidence in achieving behavioral volume targets, while noting that cash flow and earnings remain sensitive to regulatory decisions and labor market dynamics.

• Behavioral volume cadence expected to improve as leap year and weather headwinds fade
• Supplemental Medicaid timing remains outside management’s control

Takeaways

UHS’s Q1 performance underscores the importance of behavioral volume recovery and regulatory clarity, as pricing gains alone may not be sustainable. Acute care margin and cash flow discipline provide a buffer, but the company’s ability to deliver on full-year targets will depend on sequential improvement in behavioral utilization and the outcome of Medicaid program approvals.

• Behavioral Pricing Outpaces Volume: Strong managed Medicaid pricing is offsetting muted patient day growth, but this lever may weaken as industry capacity rises.
• Acute Care Execution Remains Solid: New facility openings and expense management are supporting overall margin stability.
• Watch for Regulatory and Volume Inflections: The next two quarters will be critical for behavioral volume momentum and Medicaid supplemental payment resolution.

Conclusion

UHS delivered on acute care and cost control, but the behavioral segment’s heavy reliance on price rather than volume is a key watchpoint for investors. With regulatory risk persisting and behavioral growth targets requiring a strong back-half recovery, execution and external approvals will define the company’s 2025 trajectory.

Industry Read-Through

UHS’s results highlight a sector-wide challenge: behavioral health operators are increasingly dependent on pricing gains as labor and capacity constraints limit volume growth. Acute care providers with disciplined cost structures and diversified payer mixes are better positioned to weather regulatory and macro headwinds. Medicaid supplemental payment uncertainty remains a material risk across the hospital sector, and investors should closely monitor legislative and CMS actions. Operators with exposure to new facility openings in growth markets may outperform, provided cannibalization is managed and local demand materializes.

UHS Healthcare Hospitals Behavioral Health Medicaid Volume Growth Cost Control